Core A: Mouse Core
Core A: Mouse Core
批准号:
10576378
负责人:
Mark S Anderson
金额:
$24.11万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-02-17 至 2027-01-31
关键词:
Animal HusbandryAnimalsAutoimmuneAutoimmune DiseasesAutoimmunityBiological ProcessBreedingCaringComplexDiabetes MellitusDiabetic mouseEnsureEnvironmentGenerationsGeneticHousingImmune ToleranceImmune systemImmunologic Deficiency SyndromesInbred NOD MiceIncidenceInsulin-Dependent Diabetes MellitusKnock-outMaintenanceModelingMouse StrainsMusReporterResearchResearch PersonnelSTAT3 geneTransgenic OrganismsVariantanimal facilityexperiencegain of functiongenetic makeupgenetic strainimprovedmembernovelpathogenprogramstool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
STAT3 Variants as a Rheostat of Immune Tolerance Mouse Core
Project Summary
The use of genetically altered mice has revolutionized the study of complex biological processes, including
immune tolerance and autoimmunity. All the projects in this P01 rely heavily on the use of genetically modified
transgenic, knockout, and autoimmune-prone mouse strains. Many autoimmune prone and immunodeficient
lines require specific expertise and conditions for optimal research, including housing in pathogen-free
environments. Additionally, breeding and care of such animals can become complex when dealing with
multiple genetically modified lines and different genetic strains of mice. A mouse Core is envisioned that will
help streamline and improve efficiencies with the generation and maintenance of genetically complex lines in
a healthy, pathogen-free environment. Because of the reliance of several P01 projects on the NOD mouse
model of diabetes and the novel STAT3 gain of function (GOF) mouse lines, much of the Core efforts will
revolve around the maintenance, distribution and use of these lines in combination with other relevant immune
system reporters or immunodeficient lines. In this way, the Core can help ensure the quality, genetic lineage,
and sharing of animals needed for the collaborative studies of the P01 investigators.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10328098
-
项目类别:
-
资助金额:$8.08万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Project 2: STAT3 as a trigger for T1D
-
批准号:10576386
-
项目类别:
-
资助金额:$17.54万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
STAT3 variants as a rheostat of immune tolerance
-
批准号:10328097
-
项目类别:
-
资助金额:$176.58万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Tuning peptide specifities for T cell tolerance in Type 1 diabetes
-
批准号:10630946
-
项目类别:
-
资助金额:$46.85万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity
-
批准号:10502136
-
项目类别:
-
资助金额:$64.67万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Project 2: STAT3 as a trigger for T1D
-
批准号:10328102
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Core A: Mouse Core
-
批准号:10328099
-
项目类别:
-
资助金额:$24.11万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Tuning peptide specifities for T cell tolerance in Type 1 diabetes
-
批准号:10503923
-
项目类别:
-
资助金额:$44.95万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity
-
批准号:10683384
-
项目类别:
-
资助金额:$66.63万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
STAT3 variants as a rheostat of immune tolerance
-
批准号:10576375
-
项目类别:
-
资助金额:$176.56万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Administrative Core
-
批准号:10576377
-
项目类别:
-
资助金额:$8.08万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Immune Tolerance Network
-
批准号:10625931
-
项目类别:
-
资助金额:$684.91万
-
财政年份:2021
-
负责人:Mark S Anderson
-
依托单位:
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
-
批准号:10179371
-
项目类别:
-
资助金额:$95.17万
-
财政年份:2019
-
负责人:Mark S Anderson
-
依托单位:
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
-
批准号:10413178
-
项目类别:
-
资助金额:$95.17万
-
财政年份:2019
-
负责人:Mark S Anderson
-
依托单位:
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
-
批准号:10020398
-
项目类别:
-
资助金额:$95.13万
-
财政年份:2019
-
负责人:Mark S Anderson
-
依托单位:
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
-
批准号:10762177
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2019
-
负责人:Mark S Anderson
-
依托单位:
Using human stem cell-derived thymic epithelium to remodel T1D immune tolerance
-
批准号:9106605
-
项目类别:
-
资助金额:$57.84万
-
财政年份:2016
-
负责人:Mark S Anderson
-
依托单位:
Core A - Animal core
-
批准号:9151386
-
项目类别:
-
资助金额:$25.24万
-
财政年份:2016
-
负责人:Mark S Anderson
-
依托单位:
Project 1 - Central thymic tolerance as a major checkpoint in T1D
-
批准号:9151388
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2016
-
负责人:Mark S Anderson
-
依托单位:
Disruption of T cell tolerance in type 1 diabetes
-
批准号:9291418
-
项目类别:
-
资助金额:$162.91万
-
财政年份:2016
-
负责人:Mark S Anderson
-
依托单位:
海外基金